Connect
MJA
MJA

How health technology helps promote cardiovascular health outcomes

Robyn Gallagher and Lis Neubeck
Med J Aust 2016; 205 (3): . || doi: 10.5694/mja16.00370
Published online: 1 August 2016

Health technology in the hands of cardiac patients — helpful, hindrance, or hesitate to say?

Cardiovascular disease (CVD) is a leading cause of death and hospital admissions in Australia.1 Almost a third of patients will have a recurrence such as myocardial infarction (MI), stroke, heart failure and death within 5 years.2 Reductions of at least 80% in these events can be achieved through secondary prevention behaviours, including taking cardioprotective medications as prescribed, ceasing smoking, increasing physical activity and consuming a healthy diet.3 The most comprehensive and proven of strategies to support secondary prevention is cardiac rehabilitation. This is an evidence-based, cost-effective method to reduce CVD deaths, assist recovery and promote secondary prevention through reduction of cardiovascular risk factors.


  • University of Sydney, Sydney, NSW



Competing interests:

No relevant disclosures.

  • 1. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011 (AIHW Cat. No. CVD 53). Canberra: AIHW, 2011.
  • 2. Kerr AJ, Broad J, Wells S, et al. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart 2009; 95: 125-129.
  • 3. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124: 2458-2473.
  • 4. Shore S, Jones PG, Maddox TM, et al. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Heart 2015; 101: 800-807.
  • 5. Perel P, Avezum A, Huffman M, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation roadmap for secondary prevention of cardiovascular disease. Global Heart 2015; 10: 99-110.
  • 6. Australian Bureau of Statistics. Household use of information technology, Australia, 2014–15. Canberra: ABS, 2016. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/8146.0Main+Features12014-15?OpenDocument (accessed June 2016).
  • 7. Piette JD, List J, Rana GK, et al. Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management. Circulation 2015; 132: 2012-2027.
  • 8. Park LG, Beatty A, Stafford Z, Whooley MA. Mobile phone interventions for the secondary prevention of cardiovascular disease. Prog Cardiovasc Dis 2016; 58: 639-650.
  • 9. Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA 2015; 314: 1255-1263.
  • 10. Varnfield M, Karunanithi M, Lee CK, et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart 2014; 100: 1770-1779.
  • 11. Alharbi M, Bauman A, Neubeck L, Gallagher R. Validation of Fitbit-Flex as a measure of free-living physical activity in a community-based phase III cardiac rehabilitation population. Eur J Prev Cardiol 2016; doi: 10.1177/2047487316634883 [Epub ahead of print].
  • 12. Neubeck L, Lowres N, Benjamin EJ, et al. The mobile revolution — using smartphone apps to prevent cardiovascular disease. Nat Rev Cardiol 2015; 12: 350-360.
  • 13. Singh K, Drouin K, Newmark LP, et al. Developing a framework for evaluating the patient engagement, quality, and safety of mobile health applications. Issue Brief (Commonw Fund) 2016; 5: 1-11.
  • 14. Or CKL, Karsh BT. A systematic review of patient acceptance of consumer health information technology. J Am Med Inform Assoc 2009; 16: 550-560.
  • 15. Buijink AW, Visser BJ, Marshall L. Medical apps for smartphones: lack of evidence undermines quality and safety. Evid Based Med 2013; 18: 90-92.
  • 16. Wicks P, Chiauzzi E. “Trust but verify” — five approaches to ensure safe medical apps. BMC Med 2015; 13: 205.
  • 17. Trend Micro™. How vetting mobile apps works for app stores and its users. 2014. http://www.trendmicro.com/vinfo/us/security/news/mobile-safety/vetting-mobile-apps-works-for-app-stores-and-users (accessed June 2016).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.